See our latest projects

There’s always something new happening at Celldex!
Come check out our latest activities.

Play Video


Learn about targeting EGFRvIII in glioblastoma.


About us

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.


Our Pipeline